Your Reports at Work!
From the September 2005 issue
In our January 2005 issue, we mentioned that several reporters had alerted us to the potentially confusing labeling of blister-packed RISPERDAL M-TAB (risperidone) Orally Disintegrating Tablets (see image on left). In their reports, they noted that the labels include instructions for opening the blister that are numbered 1 and 2 and that this has caused confusion due to the availability of 1 mg and 2 mg tablets. At these pharmacies where individual doses of medication were dispensed, mix-ups occurred when blister packs were removed from the original carton and placed in bins to allow easy access for dispensing and returning unused medication. At that time, we contacted Janssen to recommend a label change.
Since then, we received a similar report and again contacted Janssen. We are happy to inform you that they have agreed to make changes. As you can see, the product name and strength on the new label are much more prominent. Also, the administration directions are no longer numbered, reducing the risk of misreading the numbers as the dose. The new labeling will begin with the next batch of manufacturing, but it will probably take a few months to reach the marketplace.
|
